openPR Logo
Press release

Artificial Kidney Market is Growing at a CAGR of 13% by 2033 | Key Players: Kawasumi Laboratories Inc., Nanodialysis B.V, Fresenius SE & Co KGaA, Baxter, Asahi Kasei Medical

09-04-2025 12:59 PM CET | Health & Medicine

Press release from: Fact.MR

Artificial Kidney Market is Growing at a CAGR of 13% by 2033 | Key

Artificial Kidney Market is valued at USD 1.5 billion in 2023 and is projected to surge ahead at a CAGR of 13% to reach a market size of USD 5.3 billion by the end of 2033. This robust growth is driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), affecting millions worldwide, and the limitations of current dialysis treatments. Artificial kidneys, including wearable and implantable devices, offer a promising alternative by mimicking natural kidney functions, providing continuous filtration without the need for frequent clinic visits. The market's expansion reflects advancements in bioengineering, miniaturization, and biocompatible materials, supported by rising healthcare investments and regulatory approvals.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8509

As dialysis costs escalate and organ transplant waiting lists grow, artificial kidneys are positioned to revolutionize renal care, improving patient quality of life and reducing healthcare burdens.

Market Segmentation and Trends:

The artificial kidney market is segmented by type, end user, and region, providing a detailed view of its dynamics. Types include wearable artificial kidneys and implantable artificial kidneys. Wearable devices are gaining traction for their portability and continuous operation, while implantable ones offer long-term solutions akin to natural organs. End users encompass hospitals, specialty clinics, and ambulatory surgical centers, with hospitals leading due to their role in advanced procedures and clinical trials. Regionally, North America dominates with robust R&D, while Asia Pacific is emerging rapidly due to high CKD prevalence in countries like India and China.

Trends include the integration of nanotechnology for efficient filtration, AI for real-time monitoring, and biohybrid designs combining synthetic and biological components. The focus on miniaturization and biocompatibility aims to reduce rejection risks, with clinical trials advancing toward commercialization.

Driving Factors Behind Market Growth:

The artificial kidney market is propelled by several key factors. The global burden of CKD, affecting 10% of the population and leading to 1.2 million deaths annually, drives demand for innovative alternatives to dialysis and transplants. Limitations of current treatments, including high costs (USD 100,000+ per patient annually in the U.S.) and lifestyle restrictions, fuel interest in artificial solutions. Advancements in biomaterials and microelectronics enable compact, efficient devices, with wearable models like the WAK reducing clinic dependency. Regulatory support, such as FDA's KidneyX initiative, accelerates development.

Rising healthcare expenditures in emerging economies and aging populations increase ESRD cases, boosting adoption. Collaborations between tech firms and medical institutions, along with investments in R&D, are hastening prototypes to market. Additionally, the push for personalized medicine and remote monitoring via AI enhances patient outcomes, addressing gaps in renal care.

Browse Full Report: https://www.factmr.com/report/artificial-kidney-market

Recent Developments and Key Players:

The artificial kidney market is evolving rapidly, with key players advancing through clinical trials and partnerships. In 2023, the Kidney Project at UCSF received FDA approval for Phase I trials of its bioartificial kidney, combining bioreactor and hemofilter technologies. AWAK Technologies progressed its wearable peritoneal dialysis device, aiming for commercialization by 2025. In 2022, Qidni Labs raised funding for its implantable kidney prototype, focusing on biocompatible materials.

Prominent players include AWAK Technologies, Blood Purification Technologies Inc., Medtronic Plc, Nanodialysis B.V., Qidni Labs Inc., Triomed AB, and Wearable Artificial Organs Inc. Competitor analysis highlights a focus on miniaturization and biocompatibility. AWAK leads in wearable tech, while Qidni specializes in implantables. Strategic collaborations with universities and funding from initiatives like KidneyX drive innovation. Companies are investing in AI for device optimization and regulatory pathways to expedite approvals, targeting the growing ESRD patient base.

Regional Insights and Opportunities:

North America dominates the artificial kidney market, holding the largest share due to advanced R&D and high CKD prevalence in the United States, supported by initiatives like KidneyX. Europe follows, with strong focus on clinical trials in the UK and Germany. Asia Pacific is the fastest-growing region, driven by rising diabetes and hypertension in China and India, where governments invest in renal care infrastructure. Latin America and the Middle East & Africa offer opportunities through improving healthcare access. Emerging markets present potential via partnerships for affordable devices and technology transfer, addressing the global ESRD burden of over 2 million patients.

Challenges and Future Outlook:

The artificial kidney market faces challenges, including high development costs, regulatory hurdles for biocompatibility, and technical issues like clotting and infection risks. Limited clinical data and reimbursement policies also pose barriers. However, the market's future is promising, with opportunities in biohybrid technologies and AI integrations. As CKD cases rise to 850 million globally, advancements in nanomaterials and 3D printing will drive innovation. The market is well-positioned to nearly triple by 2033, revolutionizing renal care through portable, efficient solutions.

Check out More Related Studies Published by Fact.MR:

Artificial Organs Market https://www.factmr.com/report/3095/artificial-organs-market

Artificial Eye Lenses Market https://www.factmr.com/report/4722/artificial-eye-lenses-market

Artificial Retina Market https://www.factmr.com/report/artificial-retina-market

Artificial Insemination Market https://www.factmr.com/report/artificial-insemination-market

Veterinary Artificial Insemination Market https://www.factmr.com/report/veterinary-artificial-insemination-market

Artificial Kidney Market https://www.factmr.com/report/artificial-kidney-market

Artificial Implants Market https://www.factmr.com/report/artificial-implants-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Kidney Market is Growing at a CAGR of 13% by 2033 | Key Players: Kawasumi Laboratories Inc., Nanodialysis B.V, Fresenius SE & Co KGaA, Baxter, Asahi Kasei Medical here

News-ID: 4169996 • Views:

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for Artificial

Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences. As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making. Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc. The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs. Artificial organs are surgically implanted or are extra
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for